Parathyroid Hormone-Related Protein Inhibition Blocks Triple-Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal.
CANCER STEM CELL
EPITHELIAL TO MESENCHYMAL TRANSITION
PARATHYROID HORMONE‐RELATED PROTEIN
SKELETAL METASTASES
TRIPLE‐NEGATIVE BREAST CANCER
Journal
JBMR plus
ISSN: 2473-4039
Titre abrégé: JBMR Plus
Pays: England
ID NLM: 101707013
Informations de publication
Date de publication:
Jun 2022
Jun 2022
Historique:
received:
01
10
2021
revised:
16
11
2021
accepted:
18
11
2021
entrez:
20
6
2022
pubmed:
21
6
2022
medline:
21
6
2022
Statut:
epublish
Résumé
Parathyroid hormone-related protein (PTHrP) plays a major role in skeletal metastasis but its action mechanism has not been fully defined. We previously demonstrated the crucial importance of PTHrP in promoting mammary tumor initiation, growth, and metastasis in a mouse model with a mammary epithelium-targeted
Identifiants
pubmed: 35720668
doi: 10.1002/jbm4.10587
pii: JBM410587
pmc: PMC9189913
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e10587Informations de copyright
© 2021 The Authors. JBMR Plus published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research.
Références
Dev Cell. 2019 May 6;49(3):313-316
pubmed: 31063750
Cell Stem Cell. 2008 Jun 5;2(6):511-2
pubmed: 18522839
Histochemistry. 1987;86(6):559-65
pubmed: 3610670
Nat Cell Biol. 2016 Sep 19;18(10):1078-1089
pubmed: 27642788
Cancer. 2002 Oct 15;95(8):1706-13
pubmed: 12365018
Surg Today. 1994;24(3):215-20
pubmed: 8003863
Cancer Res. 2013 Nov 15;73(22):6574-83
pubmed: 24072746
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
J Dent Res. 2009 Jun;88(6):551-6
pubmed: 19587161
Breast Cancer Res. 2006;8(5):R59
pubmed: 17062128
Am J Med. 2003 Aug 1;115(2):115-21
pubmed: 12893397
Clin Transl Med. 2013 Jan 17;2(1):3
pubmed: 23369605
J Bone Miner Res. 2012 Jun;27(6):1231-9
pubmed: 22549910
J Clin Invest. 2011 Dec;121(12):4655-69
pubmed: 22056386
Nat Rev Cancer. 2005 Apr;5(4):275-84
pubmed: 15803154
Kidney Int. 2013 May;83(5):777-9
pubmed: 23633047
Nat Rev Clin Oncol. 2017 Oct;14(10):611-629
pubmed: 28397828
Am J Pathol. 2018 Jun;188(6):1374-1388
pubmed: 29577935
J Clin Invest. 1999 Jan;103(2):197-206
pubmed: 9916131
CA Cancer J Clin. 2015 Jan-Feb;65(1):5-29
pubmed: 25559415
J Bone Miner Res. 2010 Mar;25(3):640-52
pubmed: 19653817
J Pathol. 1997 Jun;182(2):174-9
pubmed: 9274527
Am J Cancer Res. 2013 Nov 01;3(5):500-8
pubmed: 24224127
Cell Res. 2007 Jan;17(1):3-14
pubmed: 17179981
PLoS One. 2014 Jan 22;9(1):e85803
pubmed: 24465715
Carcinogenesis. 2007 Sep;28(9):1893-901
pubmed: 17468516
J Cell Biol. 1994 Sep;126(6):1611-23
pubmed: 8089190
Cell Stem Cell. 2007 Nov;1(5):555-67
pubmed: 18371393
J Exp Clin Cancer Res. 2018 Dec 14;37(1):314
pubmed: 30547810
J Clin Endocrinol Metab. 1994 May;78(5):1268-70
pubmed: 8175989
Adv Exp Med Biol. 2019;1164:161-178
pubmed: 31576548
Cancer Res. 2009 Sep 15;69(18):7473-9
pubmed: 19723659
Am J Med. 1996 Apr;100(4):406-11
pubmed: 8610726
Cancer Res. 2006 Feb 15;66(4):2250-6
pubmed: 16489028
Cancers (Basel). 2020 May 14;12(5):
pubmed: 32423137
Sci Rep. 2017 Oct 23;7(1):13856
pubmed: 29062075
N Engl J Med. 2010 Nov 11;363(20):1938-48
pubmed: 21067385
Ecancermedicalscience. 2017 Jan 24;11:715
pubmed: 28194227
Cancer Res. 1991 Dec 15;51(24):6521-8
pubmed: 1742725
Neoplasma. 2013;60(3):290-4
pubmed: 23373998
Tumour Biol. 2012 Dec;33(6):1983-96
pubmed: 22878936
Oncotarget. 2015 May 10;6(13):11465-76
pubmed: 25888636
Cancer Discov. 2021 Jul;11(7):1774-1791
pubmed: 33589425
J Clin Invest. 2013 Mar;123(3):1348-58
pubmed: 23391723
Bull Cancer. 2001 Nov;88(11):1075-80
pubmed: 11741801
Dev Biol. 1996 Apr 10;175(1):166-76
pubmed: 8608863
Clin Breast Cancer. 2005 Feb;5 Suppl(2):S46-53
pubmed: 15807924
Endocrinology. 2014 Oct;155(10):3739-49
pubmed: 25051432
Clin Chim Acta. 2018 Aug;483:156-163
pubmed: 29709449
Anticancer Res. 2005 Nov-Dec;25(6B):3817-23
pubmed: 16309168
Cancer Treat Rev. 2010 May;36(3):206-15
pubmed: 20060649
Cancer Res. 2006 Oct 1;66(19):9339-44
pubmed: 16990346
PLoS One. 2009 Dec 21;4(12):e8377
pubmed: 20027313
J Cell Biochem. 2005 Aug 15;95(6):1178-90
pubmed: 15962290
Proc Natl Acad Sci U S A. 2008 Dec 23;105(51):20309-14
pubmed: 19091948
Am J Physiol Endocrinol Metab. 2005 Apr;288(4):E723-30
pubmed: 15572658
Front Oncol. 2021 Mar 22;11:644303
pubmed: 33828987
Nat Rev Cancer. 2003 Dec;3(12):895-902
pubmed: 14737120
Endocrinology. 1991 Nov;129(5):2466-70
pubmed: 1935781
JNCI Cancer Spectr. 2019 Aug 29;4(1):pkz063
pubmed: 32296756
Oncology (Williston Park). 2011 Jan;25(1):25-8, 30
pubmed: 21361239
Mol Cell Biol. 1992 Mar;12(3):954-61
pubmed: 1312220
Nat Rev Cancer. 2011 Jun;11(6):411-25
pubmed: 21593787
J Clin Pathol. 2011 Nov;64(11):937-46
pubmed: 21680574
Cell Stem Cell. 2007 Nov;1(5):485-7
pubmed: 18938743
J Am Soc Nephrol. 2010 Feb;21(2):237-48
pubmed: 19959711
J Clin Invest. 1996 Oct 1;98(7):1544-9
pubmed: 8833902
Carcinogenesis. 2011 May;32(5):650-8
pubmed: 21310941
Hum Pathol. 2012 Mar;43(3):364-73
pubmed: 21835433
Breast Cancer Res. 2008;10(4):210
pubmed: 18671830
Nat Genet. 2012 Jan 22;44(3):312-8
pubmed: 22267197
Br J Pharmacol. 2021 May;178(9):1923-1935
pubmed: 31087800
Science. 1996 Aug 2;273(5275):663-6
pubmed: 8662561
Cancer Res. 2000 Aug 15;60(16):4412-8
pubmed: 10969786